Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
29,651,355
-
Shares change
-
-1,444,082
-
Total reported value, excl. options
-
$64,933,187
-
Value change
-
-$3,251,935
-
Put/Call ratio
-
85%
-
Number of buys
-
14
-
Number of sells
-
-35
-
Price
-
$2.19
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q3 2021
64 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q3 2021.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29,651,355 shares
.
Largest 10 shareholders include BVF INC/IL (9,544,262 shares), NEA Management Company, LLC (9,089,041 shares), VANGUARD GROUP INC (2,260,014 shares), ACADIAN ASSET MANAGEMENT LLC (1,886,087 shares), DIMENSIONAL FUND ADVISORS LP (904,628 shares), BlackRock Inc. (875,151 shares), TWO SIGMA ADVISERS, LP (621,000 shares), RENAISSANCE TECHNOLOGIES LLC (596,100 shares), TWO SIGMA INVESTMENTS, LP (498,530 shares), and MILLENNIUM MANAGEMENT LLC (448,010 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.